Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing
about
The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolutionProtectins and maresins: New pro-resolving families of mediators in acute inflammation and resolution bioactive metabolomeResolving inflammation: dual anti-inflammatory and pro-resolution lipid mediatorsAnesthetics impact the resolution of inflammationEndogenous LXA4 circuits are determinants of pathological angiogenesis in response to chronic injury.Specialized pro-resolving lipid mediators in the inflammatory response: An updateResolution, the grail for healthy ocular inflammation.Efficacy and safety of 15(R/S)-methyl-lipoxin A(4) in topical treatment of infantile eczema.Inhaled carbon monoxide accelerates resolution of inflammation via unique proresolving mediator-heme oxygenase-1 circuits.Dysregulated heme oxygenase-ferritin system in pterygium pathogenesis.Lipoxin A4-induced heme oxygenase-1 protects cardiomyocytes against hypoxia/reoxygenation injury via p38 MAPK activation and Nrf2/ARE complexSelective activation of the prostaglandin E2 circuit in chronic injury-induced pathologic angiogenesisKnockdown of heme oxygenase-2 impairs corneal epithelial cell wound healingInterleukin-1 receptor-associated kinase-4 (IRAK4) promotes inflammatory osteolysis by activating osteoclasts and inhibiting formation of foreign body giant cells.Aspirin-triggered lipoxin A4 (15-epi-LXA4) increases the endothelial viability of human corneas storage in Optisol-GS.Estrogen negatively regulates epithelial wound healing and protective lipid mediator circuits in the corneaUVB light regulates expression of antioxidants and inflammatory mediators in human corneal epithelial cells.Female-Specific Downregulation of Tissue Polymorphonuclear Neutrophils Drives Impaired Regulatory T Cell and Amplified Effector T Cell Responses in Autoimmune Dry Eye Disease.ω-3 Tear Film Lipids Correlate With Clinical Measures of Dry Eye.Heme oxygenase-1 induction attenuates corneal inflammation and accelerates wound healing after epithelial injuryEffect of prostaglandin e2 on vascular endothelial growth factor production in nasal polyp fibroblasts.Carbon Monoxide Improves Efficacy of Mesenchymal Stromal Cells During Sepsis by Production of Specialized Proresolving Lipid Mediators.Lipoxins: resolutionary road.Signal transduction involved in lipoxin A4‑induced protection of tubular epithelial cells against hypoxia/reoxygenation injury.Essential fatty acids and their metabolites as modulators of stem cell biology with reference to inflammation, cancer, and metastasis.Heme oxygenase and ocular disease: a review of the literature.Hanging in the balance: endogenous anti-inflammatory mechanisms in tissue repair and fibrosis.The TFOS International Workshop on Contact Lens Discomfort: report of the subcommittee on neurobiology.Boosting Inflammation Resolution in Atherosclerosis: The Next Frontier for Therapy.BML-111 Attenuates Renal Ischemia/Reperfusion Injury Via Peroxisome Proliferator-Activated Receptor-α-Regulated Heme Oxygenase-1.Treating inflammation and infection in the 21st century: new hints from decoding resolution mediators and mechanisms.Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors.The role of pro-resolving lipid mediators in ocular diseases.Identification and Profiling of Specialized Pro-Resolving Mediators in Human Tears by Lipid Mediator Metabolomics.Resolution mediator chemerin15 reprograms the wound microenvironment to promote repair and reduce scarring.Diabetic macular edema, retinopathy and age-related macular degeneration as inflammatory conditionsThe Role of Periostin in the Occurrence and Progression of Eosinophilic Chronic Sinusitis with Nasal Polyps.Analysis of the Pathogenic Factors and Management of Dry Eye in Ocular Surface DisordersNon-steroidal anti-inflammatory drug delays corneal wound healing by reducing production of 12-hydroxyheptadecatrienoic acid, a ligand for leukotriene B4 receptor 2.5-Selenization of salicylic acid derivatives yielded isoform-specific 5-lipoxygenase inhibitors.
P2860
Q28260186-48B41ED1-B565-4578-951C-23101825C6FAQ28387661-3CDFFF93-4256-42B8-97B0-1BA9EE8957A2Q29615694-BFA3697C-C7BD-4A91-B325-BA1898D8CFB7Q33326614-B8F6AFCD-8ED4-499E-A01C-AEB3A55F248BQ33556241-E9930F39-E540-487D-ABD5-4AD5816D69ABQ33657562-31262A1A-D0B9-4825-A7E4-27245B3C61EDQ34126362-47E5F9E4-9E59-4807-8CEE-B6CB65AA02A1Q34290400-0AA21654-F83F-4D78-8182-06EB95C39886Q34343339-92E76BC7-DA85-42B6-9EB2-0E50105ADD0AQ34352709-B37A1844-A2EF-4722-9CE7-DE9B37E4E7BCQ34355476-2FF48C5D-93C2-4B73-8C49-EBA70AA75942Q34662175-0B238D4F-BBD2-4734-AE67-86529ED46D60Q34806151-299FCF22-47D5-481E-821B-1A41E6C7C118Q34958651-87AE79E7-FAA0-40E2-B51D-94D3BCAB494EQ35024234-B877EB29-441D-49F6-8509-C8BA5F89673EQ35863828-21C81ACA-7964-4B07-AA58-A8F8A8A23C87Q35936908-822BD9B4-EA2A-4626-B5A6-6F3B00FAF240Q36075268-DF451C35-E8B9-484D-99EF-62F6ECD8FF69Q36872931-3E48109C-C617-48A6-B6E6-8ADCA5F00028Q36952237-97FE319A-D384-45C9-9C0B-13C98F2B70A1Q36962210-CCD4AE74-EBD7-4C8D-AE46-07E4AB6DEB73Q37420143-C0BE61C5-368B-4BD8-B503-8C53AC4D4C64Q37604436-36B91A87-D2D7-4DCD-988A-90089329DB67Q37720277-E0EEB8CD-035B-445F-81AD-58744DBD9D77Q37946729-9B7EBB32-13E8-4FC1-A9C4-B0B6A5681E22Q38020531-6B4EC90E-DB1D-4919-A81A-41AA62D1915CQ38046124-E71145BE-2DA2-4EEF-9970-66BC4621AB62Q38140831-D06113A2-E259-4393-BB2F-577168B4BDB0Q38681468-35374015-0D6B-452B-924B-AEC27DB93F11Q38817418-7242CE66-46BA-44AF-AD6E-999317652FD7Q39088075-6C49F0B3-21DF-4A27-8FE9-B843C2F85B35Q39197238-0C49B5D3-86C3-4045-A4E4-EC2F474863BAQ39213940-A4852FD1-6FEA-476B-AE13-0ED517117F57Q40317977-3C4FC48A-237B-491A-B4E9-C7FC5E7F4EBDQ40926652-469E3355-E51C-414D-B5E6-AFC21B8A1D19Q41049002-BD13FC9F-864A-4D9F-87D2-A7906EF3591DQ41529243-B97598EF-91A3-4CBD-B27C-D8F1D6401319Q41574217-2BE63B6B-2A56-4F38-AEDA-5D51B6B195D4Q42378804-0B714FA5-902F-4303-B16C-2928B6564114Q43172223-A685508B-3740-4FCB-898A-630EC80E32E5
P2860
Interdependence of lipoxin A4 and heme-oxygenase in counter-regulating inflammation during corneal wound healing
description
im Juli 2007 veröffentlichter wissenschaftlicher Artikel
@de
scientific article published on 23 March 2007
@en
wetenschappelijk artikel
@nl
наукова стаття, опублікована в липні 2007
@uk
name
Interdependence of lipoxin A4 ...... n during corneal wound healing
@en
Interdependence of lipoxin A4 ...... n during corneal wound healing
@nl
type
label
Interdependence of lipoxin A4 ...... n during corneal wound healing
@en
Interdependence of lipoxin A4 ...... n during corneal wound healing
@nl
prefLabel
Interdependence of lipoxin A4 ...... n during corneal wound healing
@en
Interdependence of lipoxin A4 ...... n during corneal wound healing
@nl
P2093
P356
P1433
P1476
Interdependence of lipoxin A4 ...... n during corneal wound healing
@en
P2093
Alexander J Leedom
Benjamin Biteman
Everald Walker
Iram R Hassan
Karsten Gronert
Michael Dunn
Michal Laniado-Schwartzman
P304
P356
10.1096/FJ.06-7918COM
P407
P577
2007-03-23T00:00:00Z